When does XORTX THERAPEUTICS INC (XRTX) report earnings?
XORTX THERAPEUTICS INC (XRTX) will report earnings on 2026-03-30, after the market close.
XORTX THERAPEUTICS INC (XRTX) Forecast, Price Target & Analyst Ratings
NASDAQ:XRTX • CA98420Q3061
Current stock price
0.3715 USD
-0.01 (-2%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XORTX THERAPEUTICS INC (XRTX).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.37 to mean target of N/A, Based on 5 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
XRTX was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about XRTX.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed XRTX. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-04 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-09 | Alliance Global Partners | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||||||||
| EBITDA YoY % growth | -36.92K | N/A | -176.7K | -1.138M -543.97% | -546.1K 52.01% | -1.027M -88.10% | -2.544M -147.63% | -10.232M -302.26% | -5.906M 42.28% | -4.001M 32.26% | -3.144M 21.42% | |
| EBIT YoY % growth | -36.92K | -204.64K -454.28% | -193.5K 5.44% | -1.157M -498.04% | -566K 51.09% | -1.043M -84.19% | -2.556M -145.20% | -10.291M -302.57% | -6.046M 41.25% | -4.118M 31.88% | -3.256M 20.94% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A -127.73% | N/A 85.41% | N/A 2.31% | N/A -11.64% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
XORTX THERAPEUTICS INC / XRTX Forecast FAQ
Can you provide the analyst count for XORTX THERAPEUTICS INC stock?
The number of analysts covering XORTX THERAPEUTICS INC (XRTX) is 5.